We had a great time welcoming our incoming Cardiology Fellows at our annual Ice Cream & Cake Social with our Department Chief, @WilliamZoghbi! Here's to a fantastic year of learning, collaboration, and excellence. Welcome to the Houston Methodist family! #HMHCardio#CardioFellow
Team @IndiainNewYork wishes the people of the United States a very Happy 250th American Independence Day.
We celebrate our shared commitment to “We the People,” freedom, liberty, and democratic values.
Happy American Independence Day!
@MEAIndia@IndianEmbassyUS@IndianDiplomacy@binaysrikant76
Career advice nobody told you: You have to demonstrate excellence in everything you do. Your income scales proportional to the amount of excellence that you're able to demonstrate. Strategic incompetence is a lie. You don't get to pick and choose when to show up, because the world will ignore your best and judge you for your worst. Everything matters. Every single thing. Top performers show up with energy and enthusiasm for the little things just as much as they do for the big things. If you're in the top-10% of performers, there's no ceiling for what you can do. But the self-awareness to identify where you currently stack up, and adapt to the honest feedback on it, is very rare. If you're in the top-10%, you know it. If you're not, figure out why and fix it.
Grateful/
Had a great time writing a review. World experts coming together as co-authors, editors, n reviewers to better it and pushing me to excel! Learned a lot from every draft, comment, n revision.
Amazing community! #CardioTwitter#InterventionalCardiology#ToughLove
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal.
Read the Review Article “GLP-1 Receptor Agonists” by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, from @tuftsmedschool and the Maine Medical Center Institute for Research: https://t.co/D0XSLv7U8n
We showed that system approach can improve outcomes even for STEMI pts w NSD, challenging this group is “unmodifiable”. Supporting their inclusion in quality reporting-so hospitals stay accountable, equity improves for vulnerable patients, & STEMI health advances nationwide.